Ziel
Nox Medical has developed sleep diagnosis solutions since 2006. The company’s products are sold globally in all sleep diagnosis markets. New markets open up with simplifying medical systems using technological developments and telemedicine. Building on this, Nox Medical will develop an accessible screening solution to diagnose sleep-disorder-breathing (SDB). The prevalence of SDB is over 35% in people over 40 years old. Sleep clinics and sleep specialists cannot answer the demand for diagnosis. Nox Medical wants to bring tools to diagnose SDB to new markets, doctors not specialized in sleep medicine, allowing more patients access to diagnosis and giving doctors tools that add to and compliment their diagnosis methods.
Nox Medical will validate a biomarker for SDB screening. The biomarker is paradox movements in patients thorax and abdomen during breathing, derived from calibrated RIP belt measurements. The RIP belts monitor thorax and abdomen movements, giving information about breathing and ECG. This biomarker allows Nox Medical to screen for various forms of SDB. The solution will be developed with the diagnosis of SDB and monitoring of SDB treatment in mind and later expanded to address other pulmonary conditions.
The solution will be offered in a pay-per-use business model allowing doctors to pay for each measurement conducted. This allows new and occasional users full access to the solution without large capital investments. The business model removes the barrier of a big capital investment on the users’ part.
There is demand for a accessible screening solution. Nox Medical sees the demand through its global distributors and medical professionals, such as pediatricians and cardiologists. Nox Medical will meet the demand using a new discovery of the company to diagnose SDB and create an inexpensive, accurate, and simple to use screening- and follow up solution for doctors. The solution uses wireless smart sensors, smart phones, and a pay-per-use business model
Wissenschaftliches Gebiet
Not validated
Not validated
- medical and health sciencesclinical medicinepsychiatrysleep disorders
- social sciencespolitical sciencespolitical transitionsrevolutions
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorssmart sensors
- social scienceseconomics and businessbusiness and managementbusiness models
- medical and health sciencesbasic medicinephysiology
Programm/Programme
Thema/Themen
Aufforderung zur Vorschlagseinreichung
Andere Projekte für diesen Aufruf anzeigenUnterauftrag
H2020-SMEINST-1-2015
Finanzierungsplan
SME-1 - SME instrument phase 1Koordinator
105 Reykjavik
Island
Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen).